Bath & Body Works, Inc. (BBWI) SEC Filings & Earnings Calls
EquiReason read 13 Bath & Body Works, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-23 — Bath & Body Works granted CEO Daniel Heaf a performance stock unit award with target value of $10M tied to stock price goals over four years..
Source: SEC EDGAR filings · figures as of 2026-08-01 · read by EquiReason
- Market cap
- 4.2B
- P/E TTM
- 5.5
- Dividend yield
- 3.8%
- 52-week
- —
- Next earnings
- 18 Nov, in 25 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
23 Sep 20268-K · 5.02Bath & Body Works granted CEO Daniel Heaf a performance stock unit award with target value of $10M tied to stock price goals over four years.open
Risks flagged
Compensation tied to stock price performance may incentivize short-term actions; relative TSR modifier adds complexity.
“The number of PSUs otherwise earned will be reduced by 50% if the Company’s total shareholder return relative to the S&P 1500 Consumer Discretionary Distribution & Retail Index is below the 55th percentile.”
26 Aug 202610-QQ2 2026 net sales -2.3% YoY, operating income +37% YoY, gross margin +440 bps driven by ~$80M IEEPA tariff refunds.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q2-2026 | $1.51B | -2% y/y |
| Gross Profit · Q2-2026 | $692M | +8% y/y |
| Operating Income · Q2-2026 | $216M | +38% y/y |
| Net Income · Q2-2026 | $118M | +84% y/y |
| EPS Diluted · Q2-2026 | $0.58 | +93% y/y |
| Adjusted Operating Income · Q2-2026 | $225M | +31% y/y |
| Adjusted EPS Diluted · Q2-2026 | $0.62 | +68% y/y |
| Sales per Average Selling Square Foot · Stores - U.S. and Canada · Q2-2026 | $206.00 | -7% y/y |
| Sales per Average Store · Stores - U.S. and Canada · Q2-2026 | $586000.00 | -7% y/y |
| Store Count · Company-operated · Q2-2026 | 1,937 |
Risks flagged
Store sales decline
“Stores Net Sales decreased $65 million, or 5.4%, driven by a decrease in transactions and average dollar sales.” · word for word
Non-recurring margin benefit
“approximately $80 million of IEEPA tariff refunds” · word for word
Marketing spend increase
“Marketing Expenses increased driven by incremental spend and strategic investments to support the Consumer First Formula”
26 Aug 20268-K · 2.02, 7.01Q2 net sales $1.514B (down 2.3% YoY) and adj. EPS $0.62 exceeded guidance; full-year EPS guidance raised to $3.13-3.33 from $3.11; net sales guidance narrowed to decline 4%-2.5%; transformation progress noted.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $1.51B | -2% y/y |
| Earnings per diluted share · Q2-2026 | $0.58 | +93% y/y |
| Adjusted earnings per diluted share · Q2-2026 | $0.62 | +68% y/y |
| Operating income · Q2-2026 | $216M | +38% y/y |
| Net income · Q2-2026 | $118M | +84% y/y |
| Free cash flow · FY2026 | $650M |
Guidance
FY26 EPS raised to $3.13-3.33 from $3.11; adj. EPS raised to $2.60-2.80 from $3.21; net sales guidance narrowed to decline 4%-2.5% from prior range; Q3 EPS $0.05-0.10; Q3 adj. EPS $0.07-0.12; FY26 free cash flow ~$650M.
Full-year EPS guidance raised despite sales decline; Q3 guidance weak; management optimistic on transformation progress.
Risks flagged
Underlying business trends remain pressured despite Q2 beat; transformation still early.
“Underlying business trends remain pressured, but we are seeing further evidence that elements of the Consumer First Formula are beginning to work.” · word for word
Tariff refunds are non-recurring; excluding them adj. EPS would have been $0.31 vs reported $0.62.
“Excluding the refund benefit, second quarter 2026 adjusted earnings per diluted share would have been $0.31.” · word for word
No share repurchases assumed in outlook; limits capital return support.
“There are no share repurchases assumed in our outlook.” · word for word
20 Jul 20268-K · 7.01Bath & Body Works issued a notice of partial redemption for $250M of its 7.500% Senior Notes due 2029, with a redemption date of August 19, 2026, at 101.250% of principal plus accrued interest.open
Risks flagged
Debt redemption reduces cash reserves but lowers future interest obligations.
“Redemption price 101.250% of principal plus accrued interest.”
27 May 20268-K · 2.02, 5.02, 7.01Net Sales $1.38B (-3% y/y); Earnings per diluted share $0.90 (+84% y/y); Adjusted earnings per diluted share $0.32; Guidance: Full-year 2026 net sales decline 4.5% to 2.5%; EPS $3.00-$3.25; adjusted EPS $2.40-$2.65earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q1-2026 | $1.38B | -3% y/y |
| Earnings per diluted share · Q1-2026 | $0.90 | +84% y/y |
| Adjusted earnings per diluted share · Q1-2026 | $0.32 | |
| Operating income · Q1-2026 | $231M | +11% y/y |
| Net income · Q1-2026 | $183M | +74% y/y |
| Free cash flow · FY2026 | $600M |
Guidance
Full-year 2026 net sales decline 4.5% to 2.5%; EPS $3.00-$3.25; adjusted EPS $2.40-$2.65
Full-year guidance reaffirmed despite Q1 beat; sales decline expected to continue
Risks flagged
CFO departure creates execution risk during transformation
“CFO Eva Boratto to step down June 12; interim CFO appointed with active search”
Sales decline persists despite beat
“Q1 net sales down 3% YoY; full-year guidance implies further decline of 2.5%-4.5%”
27 May 202610-QNet Sales $1.38B (-3% y/y); Gross Profit $587M (-9% y/y); Operating Income $231M (+10% y/y); Guidance: FY2026 capex guided ~$270Mopen
Figures in the filing · each found in the filing text
| Net Sales · Q1-2026 | $1.38B | -3% y/y |
| Gross Profit · Q1-2026 | $587M | -9% y/y |
| Operating Income · Q1-2026 | $231M | +10% y/y |
| Net Income · Q1-2026 | $183M | +74% y/y |
| Net Income per Diluted Share · Q1-2026 | $0.90 | +84% y/y |
| Gross Profit Rate · Q1-2026 | 42.6% | |
| Capital Expenditures · Q1-2026 | $49M | +32% y/y |
| Cash and Cash Equivalents · Q1-2026 | $820M | +29% y/y |
| Inventories · Q1-2026 | $782M | -10% y/y |
| Sales per Average Selling Square Foot · Stores - U.S. and Canada · Q1-2026 | $194.00 | -6% y/y |
Guidance
FY2026 capex guided ~$270M
No explicit revenue or EPS guidance provided. Capex guided at ~$270M for FY2026. Management expresses optimism about Consumer First Formula but acknowledges near-term headwinds.
Risks flagged
Geopolitical risk from Middle East conflict
“the conflict between U.S. and Iran escalated and expanded to include much of the Middle East region. This has led to transportation restrictions in the region, resulting in volatility in global energy markets, commodities pricing, transportation costs and foreign currency exchange rates.” · word for word
Tariff refund uncertainty
“As of May 2, 2026, we had not recognized the effect of any potential refunds as the timing and amount of any potential refunds for previously collected tariffs was uncertain.” · word for word
Gross margin pressure from input costs
“Gross Profit rate decreased primarily due to the lower merchandise margin rate, primarily driven by tariffs, inflation and crude oil impacts as well as category mix.” · word for word
28 Apr 2026DEF 14ANet Sales $7.30B (-0% y/y); Operating Income Margin (GAAP) 15.4; Adjusted Operating Income Margin 15.9open
Figures in the filing · each found in the filing text
| Net Sales · FY2025 | $7.30B | -0% y/y |
| Operating Income Margin (GAAP) · FY2025 | 15.4% | |
| Adjusted Operating Income Margin · FY2025 | 15.9% | |
| Net Income Per Diluted Share (GAAP) · FY2025 | $3.11 | |
| Adjusted Net Income Per Diluted Share · FY2025 | $3.21 | |
| Free Cash Flow · FY2025 | $865M | |
| Dividends Paid · FY2025 | $167M | |
| Share Repurchases · FY2025 | $400M | |
| Cost Savings Target · FY2026-FY2027 | $250M | |
| Loyalty Program Members · FY2025 | 40,000,000 |
Risks flagged
Consumer demand sensitivity
“In 2025, performance was impacted significantly by consumer sentiment as consumers remained cautious and value seeking throughout the year, and by tariffs (which we did not adjust performance targets for).” · word for word
Strategic transformation execution risk
“Our ability to successfully execute this transformation is subject to various risks and uncertainties, such as our ability to successfully execute our plan, changes in consumer demands and trends, general economic conditions, and other risks.”
Tariff input cost pressure
“In 2025, performance was impacted significantly by consumer sentiment as consumers remained cautious and value seeking throughout the year, and by tariffs (which we did not adjust performance targets for).” · word for word
12 Mar 202610-KNet Sales $7.30B (-0% y/y); Operating Income (GAAP) $1.13B; Operating Income Margin (GAAP) 15.4open
Figures in the filing · each found in the filing text
| Net Sales · FY2025 | $7.30B | -0% y/y |
| Operating Income (GAAP) · FY2025 | $1.13B | |
| Operating Income Margin (GAAP) · FY2025 | 15.4% | |
| Adjusted Operating Income · FY2025 | $1.16B | |
| Adjusted Operating Income Margin · FY2025 | 15.9% | |
| Net Income (GAAP) · FY2025 | $649M | |
| Net Income Per Diluted Share (GAAP) · FY2025 | $3.11 | |
| Adjusted Net Income Per Diluted Share · FY2025 | $3.21 | |
| Free Cash Flow · FY2025 | $865M | |
| Capital Expenditures · FY2025 | $237M |
Risks flagged
Consumer demand sensitivity
“In 2025, performance was impacted significantly by consumer sentiment as consumers remained cautious and value seeking throughout the year, and by tariffs (which we did not adjust performance targets for).”
Tariff input cost pressure
“In 2025, performance was impacted significantly by consumer sentiment as consumers remained cautious and value seeking throughout the year, and by tariffs (which we did not adjust performance targets for).”
Strategic transformation execution risk
“Our ability to successfully execute this transformation is subject to various risks and uncertainties, such as our ability to successfully execute our plan, changes in consumer demands and trends, general economic conditions, and other risks.” · word for word
Seasonal concentration risk
“Our operations are seasonal in nature and the fourth quarter, including the holiday selling season, typically accounts for approximately 40% of our Net Sales and is our most profitable quarter.” · word for word
4 Mar 20268-K · 2.02, 7.01Net sales $2.72B (-2% y/y); Earnings per diluted share $1.99 (-5% y/y); Adjusted earnings per diluted share $2.05; Guidance: FY2026 net sales down 4.5% to 2.5%; EPS $3.00-$3.25; adjusted EPS $2.40-$2.65earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q4-2025 | $2.72B | -2% y/y |
| Earnings per diluted share · Q4-2025 | $1.99 | -5% y/y |
| Adjusted earnings per diluted share · Q4-2025 | $2.05 | |
| Operating income · Q4-2025 | $599M | -12% y/y |
| Net income · Q4-2025 | $403M | -11% y/y |
| Adjusted operating income · Q4-2025 | $614M | |
| Adjusted net income · Q4-2025 | $415M |
Guidance
FY2026 net sales down 4.5% to 2.5%; EPS $3.00-$3.25; adjusted EPS $2.40-$2.65
FY2026 guidance implies further sales decline; transformation costs and brand repositioning.
Risks flagged
Transformation costs and sales decline; guidance implies further revenue contraction.
“pre-tax costs of $15 million ($12 million after tax) associated with business transformation activities” · word for word
3 Mar 20268-K · 7.01Bath & Body Works issued a notice of redemption for all outstanding 6.694% Senior Notes due 2027, with redemption date April 10, 2026. This is a debt refinancing event, not a new issuance or default.open
Risks flagged
No new risk signals; redemption is a routine capital management action.
25 Feb 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen
Risks flagged
Key legal officer departure may create temporary leadership gap; search for successor underway.
“The Company has initiated a search to identify the Company’s next Chief Legal Officer.” · word for word
20 Nov 202510-QBath & Body Works reported Q3 2025 results below expectations with a 1% sales decline and 26.1% operating income drop, and management noted continued weakness into Q4.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q3-2025 | $1.59B | -1% y/y |
| Operating Income · Q3-2025 | $161M | -26% y/y |
| Net Income · Q3-2025 | $77M | -27% y/y |
| Net Income per Diluted Share · Q3-2025 | $0.37 | -25% y/y |
| Adjusted Net Income Per Diluted Share · Q3-2025 | $0.35 | -29% y/y |
| Gross Profit · Q3-2025 | $658M | -6% y/y |
| Operating Cash Flow · YTD-2025 | $225M | |
| Capital Expenditures · YTD-2025 | $174M | +5% y/y |
| Sales per Average Selling Square Foot · Stores - U.S. and Canada · Q3-2025 | $222.00 | -2% y/y |
| Sales per Average Store · Stores - U.S. and Canada · Q3-2025 | $630000.00 | -2% y/y |
Guidance
Q3 results below expectations; trends continued into Q4
Management states Q3 results were below expectations and negative trends have continued into Q4, indicating a de facto guidance cut.
Risks flagged
Consumer demand weakness
“We believe that macro consumer sentiment is weighing on our consumers’ purchase intent and that the holiday season is shaping up to be highly competitive.” · word for word
Margin compression
“Our third quarter Operating Income was $161 million, which decreased $57 million, or 26.1%, compared to the third quarter of 2024, and our Operating Income rate decreased to 10.1% from 13.5%.” · word for word
Competitive pressure
“the holiday season is shaping up to be highly competitive.” · word for word
Transformation execution risk
“We are announcing a holistic growth plan to revitalize the business across brand, product and marketplace.” · word for word
20 Nov 20258-K · 2.02, 7.01Net sales $1.59B (-1% y/y); earnings per diluted share $0.37 (-24% y/y); adjusted earnings per diluted share $0.35; Guidance: FY2025 net sales guidance from 1.5%-2.7% growth to decline of low single digits; FY2025 EPS at least $2.83 vs $3.6earningsopen
Figures in the filing · each found in the filing text
| net sales · Q3-2025 | $1.59B | -1% y/y |
| earnings per diluted share · Q3-2025 | $0.37 | -25% y/y |
| adjusted earnings per diluted share · Q3-2025 | $0.35 | |
| operating income · Q3-2025 | $161M | -26% y/y |
| net income · Q3-2025 | $77M | -27% y/y |
| free cash flow · FY2025 | $650M |
Guidance
FY2025 net sales guidance from 1.5%-2.7% growth to decline of low single digits; FY2025 EPS at least $2.83 vs $3.61 prior year
Guidance cut due to macro consumer pressures and tariff impacts.
Risks flagged
Macro consumer pressures and tariff impacts weighing on demand and margins.
“Q4 and full-year 2025 guidance lowered reflecting current business trends and continuation of recent macro consumer pressures.” · word for word
Bath & Body Works, Inc. — questions
- What did Bath & Body Works, Inc. file recently?
- 13 SEC filings in the last 12 months. Latest: 8-K on 2026-09-23 — Bath & Body Works granted CEO Daniel Heaf a performance stock unit award with target value of $10M tied to stock price goals over four years.
Every figure on this page comes from Bath & Body Works, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.